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Abstract  1 
Leukoencephalopathies are a group of white matter disorders related to abnormal 2 
formation, maintenance, and turnover of myelin in the central nervous system. These 3 
disorders of the brain are categorized according to neuroradiological and 4 
pathophysiological criteria. Herein, we have identified a unique form of 5 
leukoencephalopathy in seven patients presenting at ages two to four months with 6 
progressive microcephaly, spastic quadriparesis, and global developmental delay. 7 
Clinical, metabolic, and imaging characterization of seven patients followed by 8 
homozygosity mapping and linkage analysis were performed. Next generation 9 
sequencing, bioinformatics, and segregation analyses followed, to determine a loss of 10 
function sequence variation in the phospholipase A2-activating protein encoding gene. 11 
Expression and functional studies of the encoded protein were performed and 12 
included measurement of prostaglandin E2 and cytosolic phospholipase A2 activity in 13 
membrane fractions of fibroblasts derived from patients and healthy controls. 14 
phospholipase A2-activating protein -null mice were generated and prostaglandin E2 15 
levels were measured in different tissues. The novel phenotype of our patients 16 
segregated with a homozygous loss of function sequence variant, causing the 17 
substitution of Leucine at position 752 to Phenylalanine, in the phospholipase A2-18 
activating protein, which causes disruption of the protein's ability to induce 19 
prostaglandin E2 and cytosolic phospholipase A2 synthesis in patients’ fibroblasts. 20 
Plaa-null mice were perinatal lethal with reduced brain levels of prostaglandin E2. 21 
The non-functional phospholipase A2-activating protein and the associated 22 
neurological phenotype, reported herein for the first time, join other complex 23 
phospholipid defects that cause leukoencephalopathies in humans, emphasizing the 24 
importance of this axis in white matter development and maintenance. 25 
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Introduction 1 
Leukoencephalopathies are brain white matter disorders categorized by 2 
neuroradiological and pathophysiological criteria (van der Knaap, 2001) into:  3 
(a) Hypomyelinating diseases that are primary disturbances in myelin formation; 4 
Pelizaeus-Merzbacher disease  may be considered the prototype of hypomyelinating 5 
disorders. Additionally, Pelizaeus-Merzbacher-like diseases phenotypically resemble 6 
Pelizaeus-Merzbacher disease but are inherited as autosomal-recessive disorders. 7 
Typically, no gene is identified, but in a small subset of Pelizaeus-Merzbacher-like 8 
diseases patients, sequence variations in gap junction protein alpha 12, coding for 9 
connexin 46.6 (Henneke et al., 2008; Uhlenberg et al., 2004), and sequence variations 10 
in the gene HSPD1, coding for heat shock 60-kDa protein 1, have been found (Magen 11 
et al., 2008). This group also includes syndromes in which hypomyelination is 12 
accompanied by other multi-organ involvements such as Cockayne's and 13 
Trichothiodystrophy Syndromes (Weidenheim et al., 2009), and Oculodentodigital 14 
Dysplasia and 4H Syndrome (Atrouni et al., 2003; Timmons et al., 2006). 15 
 (b) Dysmyelinating disorders with delayed and disturbed myelination, including most 16 
amino-acidopathies and organic acidurias. Since the brain (especially glial cells) is 17 
very sensitive to accumulation of toxic metabolites, secondary white matter 18 
abnormalities can be diagnosed in many metabolic disorders. Dysmyelination is also a 19 
main pattern of rare disorders such as SOX10-Associated Syndromes (the neurologic 20 
variant of Waardenburg-Shah Syndrome) (Pusch et al., 1998). Affected patients 21 
present a variable range of neurological symptoms: developmental delay, spasticity, 22 
ataxia, nystagmus, and in severe cases, profound neonatal hypotonia and congenital 23 
arthrogrypposis due to peripheral hypomyelination. 18q Deletion Syndrome, another 24 
example for disorders in this category, is characterized by neurological features such 25 
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as mental retardation, microcephaly, hypotonia, nystagmus and seizures, accompanied 1 
by additional multisystem defects, including partial growth hormone deficiency, 2 
facial, external ear, cardiac, and skeletal defects. Regions for dysmyelination, 3 
congenital aural atresia, and growth hormone insufficiency (18q22.3-q23) were 4 
identical and contained 5 known genes, including the myelin basic protein encoding 5 
gene. The dysmyelination region was 100% penetrant (Feenstra et al., 2007).  6 
(c) The third group is disorders with progressive demyelination, including "classic" 7 
leukodystrophies: X-linked adrenoleukodystrophy, Alexander's disease, 8 
Metachromatic leukodystrophy, Krabbe's disease, and disorders with white-matter 9 
vacuolisation such as Canavan's disease and Vanishing White Matter disease. 10 
(d) Several leukoencephalopathi s present with cystic degenerations, including 11 
megalencephalic leukoencephalopathy with subcortical cysts, first described by van 12 
der Knaap et al. in 1995 (van der Knaap et al., 1995). Early-onset macrocephaly and 13 
delayed-onset neurologic deterioration, including cerebellar ataxia, spasticity, 14 
epilepsy, and mild cognitive decline, are characteristic features. Cystic 15 
leukoencephalopathy without megalencephaly has also been described (Henneke et 16 
al., 2009). 17 
 (e) Disorders secondary to axonal damage include the autosomal recessive disorder 18 
giant axonal neuropathy.  Patients present with progressive gait disturbances due to 19 
peripheral neuropathy, mental retardation, optic atrophy and spasticity; brain imaging 20 
studies show leukoencephalopathy. Pathological hallmarks of giant axonal neuropathy 21 
are axonal loss and axonal swellings filled with neurofilaments on nerve biopsy (Tazir 22 
et al., 2009). Giant axonal neuropathy is caused by sequence variation in GAN 23 
encoding for gigaxonin, located on chromosome 16q24 (Bomont et al., 2000). 24 
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Nevertheless, 50% of patients with leukoencephalopathies remain without specific 1 
diagnosis. 2 
We report seven individuals from two consanguineous families presenting a unique 3 
phenotype of severe spastic quadriparesis, progressive microcephaly, thin corpus 4 
callosum, significant startle response, and severe global developmental delay. Genetic 5 
investigation revealed a novel missense variant in the phospholipase A2-activating 6 
protein (PLAA) gene and disclosed a new mechanism required for normal 7 
development and maintenance of central nervous system white matter.   8 
Methods 9 
Patients 10 
The Israeli Ministry of Health Ethics Committee for genetic experiments approved 11 
the proposed studies. Seven affected and twenty-three healthy individuals from two 12 
consanguineous families were enrolled in the study; they or their legal guardians 13 
provided written, informed consent. Clinical investigations included medical 14 
procedures, imaging and electrophysiological studies, and muscle biopsies. Skin 15 
biopsy was performed as part of the research protocol.  16 
Molecular studies  17 
Genetic Linkage Analysis 18 
Linkage and haplotype analyses were performed as previously described (Zivony-19 
Elboum et al., 2012).  20 
An analysis of 2050 polymorphic markers, spread across the genome at approximately 21 
2cM intervals was performed for 9 family members. Statistical analysis of the 22 
logarithm of the odds (LOD) score was performed using the Pedtool-superlink tool. 23 
Areas with high LOD score were further examined using Linkage Mapping Set v2.5 24 
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HD5 kit and v2.5 MD10 (Applied Biosystems, Grand Island, NY) on 24 family 1 
members, according to the manufacturer's protocol. 2 
Molecular Inversion Probes and Massively Parallel Sequencing 3 
Molecular Inversion Probes were designed as described (Teer et al., 2010) to cover 4 
the 2Mb of the candidate region (LC Sciences, Houston, TX). A total of 6498 5 
amplimers had an average length of 433bp (+/-22bp). The amplimers covered 97% of 6 
the candidate region. DNA capture, library preparation, GAIIx sequencing (Illumina, 7 
San Diego, CA), and data analysis were performed as described (Teer et al., 2010). 8 
Potential variants were filtered and visualized with VarSifter (Teer et al., 2012). 9 
Sanger Sequencing 10 
For dideoxy sequencing, primers were designed to cover the candidate sequence 11 
variations (primer sequences available upon request).  Direct sequencing of the 12 
polymerase chain reaction (PCR) amplification products was performed using BigDye 13 
3.1 Terminator chemistry (Applied Biosystems) and separated on an ABI 3130xl 14 
genetic analyzer (Applied Biosystems). Data were evaluated using Sequencher v5.0 15 
software (Gene Codes Corporation, Ann Arbor, MI).  16 
Molecular Modeling 17 
Molecular modeling of the PLAA protein and assessment of the sequence variation 18 
impact was performed using the PyMOL Molecular Graphics System (Schrödinger, 19 
New York, NY) (Baugh et al., 2011). 20 
Expression analyses 21 
Reverse Transcription of Full-Length PLAA Transcript 22 
Primary fibroblasts [from healthy controls (nPLAA) and patients (mPLAA)] were 23 
harvested from one near-confluent 25 cm2 flask and RNA extracted using the RNeasy 24 
mini kit (Qiagen, Valencia, CA). RNA samples were quantified using a Nanodrop 25 
Page 9 of 62
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 9
Spectrophotometer (Nanodrop Technologies, Wilmington, DE) and qualified by 1 
analysis on an RNA NanoChip using the Agilent 2100 Bioanalyzer (Agilent 2 
Technologies, Santa Clara, CA). Synthesis of complimentary DNA (cDNA) was 3 
performed using the Taqman Reverse Transcription Reagents Kit (Applied 4 
Biosystems). The reaction conditions were as follow: 10 min at 25ºC; 30 min at 48ºC; 5 
and 5 min at 95ºC. PCR amplifications of cDNA were performed using FailSafe 6 
buffer C (Epicenter Biotechnologies, Madison, WI) with PLAA primers 7 
5’CGAGCGGCGCAACCAGGTACC3’ and 8 
5’GCATTCACTTACTTTAGCTGGTTCTG3’ at a final concentration of 1 µM.  9 
Thermal conditions for 40 cycles of PCR were as follow: 94ºC for 30 sec, 60ºC for 30 10 
sec, and 68ºC for 7 min. 11 
Real Time (RT)-quantitative (q)PCR 12 
One µg of RNA extracted from fibroblasts from healthy controls and patients was 13 
subjected to cDNA synthesis followed by RT-qPCR using the iTaq Universal SYBR 14 
Green mix (Bio-Rad, Hercules, CA).  The final concentration of the PLAA primers 15 
(5’GACT TGGGAATCCC AGCTTTTC3’ and 16 
5’TTCCCATACTTGCAGAACCTG3’; Accession # NM_001031689) was 300 nM.  17 
RT-qPCR assays were performed with human 18S RNA, glyceraldehyde 3-phosphate 18 
dehydrogenase (GAPDH), L19 ribosomal protein, and polymerase beta (PolB) as 19 
housekeeping protein encoding genes to normalize PLAA transcript levels.  Absolute 20 
analysis was performed using known amounts of a synthetic transcript of the gene of 21 
interest.  All RT-qPCR assays were run on the ABI Prism 7500 Sequence Detection 22 
System and the conditions were as follow: 50oC for 2 min, 95oC for 10 min, and then 23 
40 cycles of 95oC for 15 sec and 60oC for 1 min. The results shown were the averages 24 
and standard deviations from three independent experiments performed in triplicate. 25 
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 1 
The pro-inflammatory gene expression in fibroblasts with nPLAA or the mPLAA gene 2 
was carried out using the appropriate assays-on-demandTM gene expression assay mix 3 
consisting of a 20X mix of unlabeled PCR primers and TaqMan® MGB probe, 4 
FAMTM dye-labeled (Life Science Technology Inc, CA).  Human GADPH, β-actin, 5 
and 18S RNA encoding genes were used to normalize transcripts for various 6 
cytokines. The primer sequences for various cytokine genes are available upon 7 
request. The reactions were carried out according to the manufacturer’s instruction 8 
using a Bio-Rad Q5 RT-qPCR machine. The results shown were the averages and 9 
standard deviations from three independent experiments performed in triplicate. 10 
Western blot analysis 11 
β-catenin. Briefly, 70 µg of protein samples from healthy controls' and patients' 12 
fibroblasts with or without lipopolysaccharide [LPS; 10 µg/mL] stimulation) were 13 
electrophoresed on 4-20% Mini-Protean TGX Pre-cast Tris/Glycine gels (Bio-Rad) 14 
and then transferred to nitrocellulose membranes.  The membranes were probed with 15 
non-phospho (active) β-catenin (Cell Signaling Technology, Danvers, MA) and β-16 
Tubulin (Santa Cruz) antibodies as described by the manufacturer.  An anti-rabbit 17 
horseradish peroxidase conjugated secondary antibody (Southern Biotech, 18 
Birmingham, AL) was then added, and proteins detected by using enhanced 19 
chemiluminescence with Super Signal West Femto Maximum Sensitivity substrate 20 
(Thermo Scientific).  The membranes were then imaged with GE ImageQuant LAS 21 
4000 (General Electric, Fairfield, CT). 22 
Biochemical studies 23 
Measurement of Prostaglandin E2 (PGE2) 24 
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Primary human fibroblasts from healthy controls and patients were grown in Dulbecco 1 
modified essential medium with 15% fetal bovine serum at 37°C and 5% CO2. 2 
Fibroblasts from patients and control subjects were treated with 10 µg/mL LPS or 3 
cholera toxin for 24 hours; and the cell culture supernatants were collected. PGE2 4 
levels were determined using enzyme immunoassay kit (Cayman Chemicals, Ann 5 
Arbor, MI). To examine PGE2 levels in mouse tissues, samples were subjected to 6 
solid phase extraction on C18 columns (Cayman Chemicals) prior to measurements.  7 
Preparation of Membrane Fractions from Fibroblasts 8 
Membrane fractions from healthy controls and patients' unstimulated and LPS-9 
stimulated fibroblasts were isolated using established procedures (Zhang et al., 2008). 10 
Protein concentrations in membrane fractions were determined using Bradford Protein 11 
Reagent (Bio-Rad). 12 
Measurement of Cytosolic Phospholipase A2 (cPLA2) Activity 13 
The cPLA2 activity in membrane fractions of fibroblasts from patients and healthy 14 
controls) was determined using PLA2 activity kit (Cayman Chemicals). The 15 
enzymatic activity was normalized to protein concentration for each sample. Bee 16 
Venom PLA2 was used as a positive control. 17 
Complementation studies 18 
Fibroblasts from patients (mPLAA) or healthy controls (nPLAA) were grown and 19 
electroporated with the recombinant plasmid or the vector alone using Lonza 20 
Nucleofector and Human Dermal Fibroblast kit (Lonza, Basel, Switzerland). The 21 
mPLAA fibroblasts were electroporated with either CMV promoter-based pIRES2-22 
DsRed2-nPLAA for complementation or pIRES2-DsRed2 vector (Clontech, Mountain 23 
View, CA) alone as a control. nPLAA fibroblasts were also electroporated with the 24 
vector alone to serve as an additional control.  25 
Page 12 of 62
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 12
Mouse model 1 
All animal experiments were performed at the University of Texas Medical Branch. 2 
Animals were housed in a specific-pathogen free facility at a constant temperature 3 
(68-79oF) and humidity (30-70%) on a 12 hours light-dark cycle. Autoclaved water 4 
and irradiated feed were given to the animals ad libitum. All procedures were 5 
performed in accordance with the protocol reviewed and approved by University of 6 
Texas Medical Branch Institutional Animal Care and Use Committee, and in 7 
compliance with the institutional policies/guidelines and the Guide for the Care and 8 
Use of Laboratory Animals, 8th edition.  Euthanasia methods used in the procedures 9 
were consistent with the American Veterinary Medical Association Guidelines for the 10 
Euthanasia of Animals, 2013 edition.  Generation of Plaa-null mice (Plaa gene 11 
targeting) and genotyping of the mice have been described in Supplemetary Materials 12 
and Methods section. 13 
Preparation of Mouse Tissue Samples for PGE2 Measurements 14 
In brief, mouse tissues were suspended in homogenization buffer (0.1M disodium 15 
phosphate buffer, pH 7.4, 1 mM EDTA, 10 µM indomethacin) and sonicated. 16 
Samples were normalized by measuring protein concentrations using the Bradford 17 
Protein Reagent (Bio-Rad). After homogenization, 4 volumes of ethanol were added 18 
and samples centrifuged at 3000 x g for 10 min at 4°C. Supernatants were collected 19 
and ethanol removed by vacuum centrifugation before acidification of the samples 20 
with 1M acetate buffer. The samples were then loaded on pre-washed C18 cartridges, 21 
washed with H2O, and eluted with ethyl acetate and 1% methanol (99:1 v/v). Ethyl 22 
acetate was removed by vacuum centrifugation and samples reconstituted in PGE2 23 
assay buffer for measuring PGE2. 24 
Histopathology 25 
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Sections (5 µm) representing skin, lungs, and the brain cerebral cortex from 1 
embryonic day (E) 18.5 mouse embryos were fixed in 10% neutral buffered formalin. 2 
The tissue sections were mounted on slides and stained with hematoxylin and eosin. 3 
The histopathological evaluation of the tissue sections was performed in a blinded 4 
fashion. 5 
Statistical analysis 6 
Where appropriate, at least three independent experiments were performed in 7 
triplicate and data analyzed using one-way ANOVA with Tukey or Tukey post-hoc 8 
correction. 9 
10 
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Results 1 
Patients 2 
Seven individuals from two families, all products of consanguineous marriages and 3 
uneventful pregnancies, presented with progressive leukoencephalopathy (Figure 4 
1A&B), defined as dysmyelinating according to the known categories of Van der 5 
Knaap and his colleagues (van der Knaap, 2001). Affected individuals were normal at 6 
birth, with onset of neurological symptoms at age 2-4 months (Table 1). Symptoms 7 
included spasticity of lower limbs rapidly progressing to upper extremities, resulting 8 
in severe quadriparesis with symptoms of corticospinal tract impairment and posture 9 
deformation. Involvement of extrapyramidal system function included dystonic 10 
posturing, rigidity/freezing, and hypomimia/amimia. All patients suffered from severe 11 
mental and language developmental delay. The motor functions were also 12 
prominently impaired (level V, according to Gross Motor Function Classification 13 
System (Palisano et al., 1997). Abnormally exaggerated startle reflex to an auditory 14 
stimulus was observed in 6 patients, and seizures developed in three.  15 
Head circumferences, normal at birth, decreased to more than 2 standard deviation 16 
below the mean in the ensuing years. In two patients, we observed an unexplained 17 
gradual increase in Head circumferences  up to 75% after the age of approximately 5 18 
years. Weight and height, also normal at birth, fell to 3-4 SD below mean in 5 patients 19 
but returned to 50-75% in two out of five patients. Progressive chest deformities 20 
(kyphosis/pectus carinatum) were observed in all patients. Additional phenotypic 21 
characteristics included contractures of large joints, hyperextensibility of small ones, 22 
rocker bottom feet, hypertrichosis, and hyperhidrosis of palms and feet (Figure 1C, a-23 
d).  24 
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Brain MRI demonstrated radiological signs of periventricular and subcortical damage 1 
including delayed myelination and atrophy, which worsened with age as a result of 2 
enlargement of ventricular system. Thin corpus callosum was a prominent feature in 3 
all of the patients. In one case, periventricular lesions were observed (Figure 1D). 4 
Muscle biopsy in patient VI3 showed normal oxidative phosphorylation and increased 5 
aggregation of collagen.  6 
Molecular analyses 7 
Molecular Studies 8 
Linkage analysis, performed on 24 individuals from family I, identified a 1.9Mb 9 
region between markers D9S265 and rs1330920 with a maximal LOD score of 3.24 at 10 
D9S1121; the region contained 11 genes (Figure 2A&B). Seven samples were 11 
sequenced (two affected, 2 obligate carriers, and 3 unaffected individuals from the 12 
same village) with an average coverage of 82 + 2% (all coding regions were covered). 13 
Haplotype analysis (D9S259-D9S169) supported a common ancestral haplotype in 14 
families A and B (Table S1).  15 
Next Generation Sequencing  16 
A total of 4289 variants were identified, but only four of them affected protein 17 
sequences (Table S2). Out of these four variants, only one was present in a 18 
homozygous state in the affected individuals and in a heterozygous state in the 19 
obligate carriers. The three others were identified in the samples of unaffected 20 
individuals. The missense variant, NM_001031689.2: c.2254C>T (p.Leu752Phe); was 21 
confirmed by Sanger sequencing (Figure 2C) in all affected individuals and obligate 22 
carriers. All seven affected individuals were homozygous for this sequence variation; 23 
all their parents were heterozygous.  24 
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The above PLAA variant (p.Leu752Phe) was neither observed in the Exome 1 
Aggregation Consortium (60.706 unrelated individuals, Exome Aggregation 2 
Consortium [ExAC], Cambridge, MA, http://exac.broadinstitute.org/, accessed 3 
February 2016) nor in the NHLBI database (6,500 unrelated individuals, Exome 4 
Variant Server, NHLBI GO Exome Sequencing Project, Seattle, WA [URL: 5 
http://evs.gs.washington.edu/EVS/] accessed February 2016). Population screening of 6 
92 healthy village residents revealed 3 carriers of this sequence variation (prevalence 7 
3.3%). 8 
The leucine at position 752 in PLAA is highly conserved through Saccharomyces 9 
cerevisiae (Figure 2D), with the exclusion of Zebrafish (threonine) and 10 
Caenorhabditis elegans (valine). This amino acid substitution is predicted to be 11 
deleterious by SIFT (Score: 0.04) 12 
(http://sift.jcvi.org/www/SIFT_aligned_seqs_submit.html) and probably damaging by 13 
PolyPhen-2 (Score 0.983) (http://genetics.bwh.harvard.edu/pph2/index.shtml).  14 
Structural Effects of p.Leu752Phe substitution in PLAA 15 
The structure of PLAA PUL domain, in which Leu752 resides, was recently 16 
determined with atomic resolution (Qiu et al., 2010). PUL domain consists of 15 17 
tightly packed α-helices forming a 6-mer Armadillo domain. This protein fold consists 18 
of tightly packed helices in a single rigid structure found in several proteins such as 19 
importin-α, β-catenins, and Hsp70 binding protein (Hatzfeld, 1999). The Armadillo 20 
domain of PLAA is held together mainly through conserved leucine residues that zip 21 
together adjacent α-helices. On average, leucine is present every 3-4 residues, 22 
corresponding to one turn of the helical wheel. Such Armadillo repeats form banana-23 
shaped domains that generate good binding surfaces, particularly on the inside 24 
curvature (Hatzfeld, 1999).  25 
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In PLAA, the putative binding site is also paved with conserved residue  (Sievers et 1 
al., 2011). Based on these data, p.Leu752Phe mutation appears to disrupt the tightly 2 
packed leucine network of the PLAA PUL domain and deform the banana-like 3 
binding surface (Figure 2E).  4 
Expression studies 5 
PLAA mRNA Expression  6 
At the transcriptional level, fibroblasts from patients were capable of expressing full 7 
length PLAA transcript similar to that of nPLAA fibroblasts (Figure 3A). Furthermore, 8 
based on RT-qPCR, no difference in the levels of PLAA transcript was noted between 9 
nPLAA versus mPLAA fibroblasts (Figure 3B). As amino acid changes can have 10 
unexpected effects on protein stability, we sought to confirm production of PLAA 11 
protein in fibroblasts with and without the defined mutation in the PLAA gene. 12 
Confocal microscopy was performed to localize PLAA in normal and patient 13 
fibroblasts. All patient fibroblasts tested showed some localization of PLAA in the 14 
nucleus and majority of PLAA in the cytoplasm, which were similar in levels found in 15 
the fibroblasts of healthy controls (Figure 3C&D).  16 
Functional Effects of p.Leu752Phe on PLAA 17 
Previous studies showed that PLAA loss causes severe ubiquitin depletion, 18 
accumulation of misfolded proteins, and impaired cellular survival, in S. cerevisiae 19 
(Mullally et al., 2006; Qiu et al., 2010). However, these effets were neither shown in 20 
the growth of S. cerevisiae and its ∆DOA1 (an ortholog of human PLAA in yeast) 21 
mutant nor on ubiquitin depletion in fibroblasts from healthy controls versus patients. 22 
(See methods and results in the supplementary section.) Consequently, we examined 23 
other known functions of the PLAA protein. PLAA induces PGE2 production by 24 
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increasing levels of PLA2 and cyclooxygenase (COX)-2 proteins, two major 1 
regulators of prostaglandins (Calignano et al., 1991; Zhang et al., 2008).  2 
Investigating this function, we measured PGE2 levels in our patients' fibroblasts. 3 
Healthy, unstimulated cells expressing nPLAA exhibited ~2-fold higher levels of 4 
PGE2 compared to patients’ fibroblasts (Figure 4A black bars); this difference 5 
became much more prominent after LPS and cholera toxin treatment of the cultured 6 
nPLAA cells (~5000-fold [light gray bars] and ~1000-fold [dark gray bars], 7 
respectively). LPS treatment induced cPLA2 activity in normal fibroblasts, but did not 8 
elicit a similar response in patients' cells (Figure 4B). These results suggest that 9 
p.Leu752Phe in PLAA abrogates its ability to induce prostaglandin biogenesis and 10 
properly respond to related stresses. Finally, transfection with a plasmid expressing 11 
nPLAA rescued PGE2 levels and cPLA2 activity in both untreated and LPS-stimulated 12 
patients' fibroblasts (Figure 4C&D).  13 
We previously observed that PLAA regulates NF-κB-mediated inflammatory 14 
responses, and in particular inducible interleukin (IL)-6 (Zhang et al., 2008). Herein, 15 
we observed that p.Leu752Phe variation in PLAA abrogated expression of LPS 16 
induced IL-6, IL-8, and macrophage migration inhibitory factor (MIF) expression in 17 
patient fibroblasts when compared to fibroblasts from a representative healthy control 18 
based on RT-qPCR (Figure 4E-G).  19 
Cell Biology studies 20 
NF-кB Recruitment to the Nucleus is Unaffected by p.Leu752Phe in the PLAA.  21 
We investigated the NF-кB signaling pathway which is known to be regulated by 22 
PLAA (Zhang et al., 2008) and show it is intact in both fibroblasts from patients and 23 
healthy controls (Figure S1A&B). For detailed methods, results and figure see the 24 
suplementary section. 25 
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β-catenin wingless integration (Wnt) Signaling is Not Affected by p.Leu752Phe PLAA 1 
We investigated Wnt signaling by examining levels of non-phospho (active) β-catenin 2 
in nPLAA versus mPLAA fibroblasts with and without LPS stimulation.  As shown in 3 
Figure S1C, the levels of active β-catenin were increased after LPS stimulation to a 4 
similar extent in both types of fibroblasts. Detailed results are summarized in the 5 
supplimentary section. 6 
Mouse model 7 
Inactivation of the Plaa Gene Results in Perinatal Lethality in Mice  8 
We generated Plaa-null mice using gene targeting technology (Figure S2). While 9 
heterozygous (Plaa+/-) mutants were viable and fertile, the homozygous (Plaa-/-) 10 
mutants exhibited perinatal lethality. Initially we genotyped 66 pups derived from 11 
heterozygous intercrosses, typically on postnatal day 4-9.  Twenty-eight pups were 12 
wild-type, thirty-eight were Plaa+/-, and there was no Plaa-/- mutant. To determine 13 
when the Plaa-null mice died, we set up timed heterozygous intercross mating and 14 
examined embryos at different time points (Table S3). At E14.5, we recovered live, 15 
overtly normal Plaa-/- embryos, which were indistinquishable from Plaa+/- or wild-16 
type littermates. At E18.5, we found mostly live (with a beating heart) but some dead 17 
Plaa-/- embryos. Plaa-/- embryos were grossly normal but smaller than Plaa+/- or wild-18 
type littermates. The average body weights of live Plaa-/-, Plaa+/-, and wild-type 19 
embryos were 0.83 ± 0.11 g (n=14), 1.03 ± 0.17 g (n=32), and 1.34 ± 0.14 (n=9) at 20 
E18.5, respectively. While differences in weights between wild-type and Plaa+/- were 21 
not statisitcally significant, weight differences between wild-type and Plaa-/- 22 
(≤0.0001) and Plaa-/- and Plaa+/- (≤0.001) were significant by one way ANOVA with 23 
Tukey post hoc correction. 24 
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Gross examination revealed that all of the near-term Plaa-/- embryos had abnormal or 1 
underdeveloped spleens, which were transparent/pale and smaller. Interestingly, we 2 
also found one embryo with exencephaly/microcephaly among a total of 41 Plaa-/- 3 
embryos examined. We attempted to resuscitate some of the E18.5 embryos, but Plaa-4 
/-
  embryos could not be resuscitated. While Plaa+/- and wild-type embryos reacted to 5 
the pinch and started gasping for air, Plaa-/- embryos did not make any voluntary or 6 
involuntary movement. Subsequently, we also found five Plaa-/- neonates that were 7 
naturally delivered, but they were all found dead. Notably, one of the dead Plaa-/-8 
 neonates had posterior truncation. The dead Plaa-/- neonates appeared to have no air 9 
in their lungs. To date, we have not found any live Plaa-/- neonate. These observations 10 
suggest that Plaa-null mice likely died shortly before or after birth.  11 
A Tissue-Specific PGE2 Reduction and Perinatal Lethality of Plaa-Null Mice 12 
 To validate the results observed for the human fibroblasts carrying mPLAA, we 13 
evaluated the levels of PGE2 in wild-type, Plaa+/-, and Plaa-/- embryos. We isolated 14 
lungs, brain, liver, and heart tissues from E18.5 embryos, and determined PGE2 levels 15 
for each organ individually (Figure 5A-D). In the brain, there was a gene copy 16 
dependent reduction of PGE2 with significant reduction in Plaa+/- embryos compared 17 
to wild-type (p<0.001) as well as a significant decreased level of PGE2 in Plaa-/- 18 
compared to Plaa+/- (p<0.05) embryos (Figure 5B). PGE2 levels were significantly 19 
decreased in Plaa-/- lungs, and Plaa+/- and Plaa-/- hearts, but not in the liver (Figure 20 
5A,C&D). It is unclear why gene copy dependent reduction of PGE2 was noted in 21 
some organs but not in others. 22 
Histopathological Analysis of Skin, Lungs, and Brain Cerebral Cortex of Plaa-Null 23 
Mice 24 
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As shown in Figure 6A, lungs from WT mice embryos exhibited the presence of 1 
organized alveolar spaces and thin alveolar walls. However, embryos from Plaa+/- and 2 
Plaa-/-mice showed progressively unorganized alveolar spaces and thickening of the 3 
alveolar walls, suggesting underdeveloped or immature lungs. 4 
In the brain cerebral cortex of wild type embryos, the neurons showed large nuclei 5 
and were fully matured, with no indication of degeneration. No signs of apoptotic 6 
bodies were noted. There were a few round dark cells that represented either 7 
oligodendroglia or granular immature neurons (Figure 6B). The Plaa+/- embryos had 8 
smaller neuronal nuclei and about the same density of the round dark cells.  On the 9 
contrary, Plaa-/- embryos had a vast area of neurons with smaller dark-stained round 10 
nuclei that could be described generally as “more granular” in type, an indication of 11 
less maturity and differentiation. No significant differences were observed in the skin 12 
of wild type versus mutant mouse embryos (Figure 6C). Typical tissue sections 13 
representing multiple fields and from 2-4 embryos are shown.     14 
Discussion  15 
PLAA is a regulatory molecule implicated in modulating production of host cell 16 
phospholipases (e.g., PLA2) (Clark et al., 1991; Ribardo et al., 2002). Induction of 17 
PLA2 is highly regulated by mitogen-activated protein kinases and NF-κB (Zhang et 18 
al., 2008). PLA2 hydrolyzes membrane phospholipids to produce arachidonic acid, 19 
which is used as a substrate to produce prostaglandins and leukotrienes (eicosanoids) 20 
through cyclooxygenase and lipoxygenase pathways, respectively (Ribardo et al., 21 
2002).  22 
In this report, we present seven patients from two families with severe, unique, 23 
progressive leukoencephalopathy. Based on the clinical and radiological findings, 24 
these patients could be categorized into the group of primary delay in myelin 25 
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formation and disturbed myelination (van der Knaap, 2001). Brain biopsies were not 1 
performed and histopathological data are not available to confirm or rule out our 2 
clinical impression. 3 
All patients are homozygous for a founder sequence variant (p.Leu752Phe) in PLAA. 4 
that did not lead to the production of unstable transcript or protein.  5 
The PLAA protein is composed of three major domains: N' terminal, multi-protein 6 
complex assembly domain contains 7 WD40 repeats; central PFU domain includes a 7 
ubiquitin binding region and an SH3 region; and C' terminal PUL domain consists of 8 
6 Armadillo repeats and binds to valosin-containing protein, also known as Cdc48 and 9 
p97 (Qiu et al., 2010). Our results suggest that the p.Leu752Phe sequence variant 10 
disrupts the protein’s Armadillo domain, possibly impairing cells' ability to induce 11 
prostaglandin production through a non-NF-кB signaling pathway.  12 
Armadillo folds such as those found in PLAA, importin-α, and β-catenins, play a role 13 
in central nervous system development in Drosophila. Specifically, disruption of cell-14 
cell adhesion function of Armadillo results in construction defects of the axonal 15 
scaffold (Loureiro and Peifer, 1998). Interestingly, a recent study suggested that 16 
PLA2α regulates the Wnt/β-catenin pathway (Han et al., 2008), which is implicated in 17 
neurogenesis, central nervous system morphogenesis, hirsutism, sweat gland 18 
morphology, short tendons, and kyphosis (Haara et al., 2011 ; Joksimovic and 19 
Awatramani, 2014; Toribio et al., 2010; Zhang et al., 2014).  In this pathway, β-20 
catenins transduce Wnt signals during embryonic development. Therefore, we 21 
hypothesized that PLAA, which activates PLA2, indirectly regulates the Wnt/β-22 
catenin pathway, accounting for the pathology seen in our patients. However, our data 23 
indicate that the p.Leu752Phe in PLAA found in our patients did not alter Wnt 24 
signaling.  25 
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Experimentally, activation of PLAA was recently shown to occur via 1α,25(OH)2D3 1 
binding to a specific membrane-associated receptor, Pdia3, in caveolae, regulating 2 
growth zone chondrocytes (Doroudi et al., 2014). These findings might explain non-3 
neurological features of progressive chest deformities (kyphosis/pectus carinatum) 4 
present in affected individuals. 5 
Complex phospholipid defects involving the central nernous system have received 6 
much attention of late (Lamari et al., 2013), providing insights into late-onset 7 
neurodegenerative disease pathophysiology, such as gene PLA2G6 encoding PLA2, 8 
underlying AR infantile neuroaxonal dystrophy, neurodegeneration associated with 9 
brain iron accumulation, and early-onset dystonia/parkinsonism (Gregory et al., 2008; 10 
Khateeb et al., 2006).  11 
Furthermore, PGE2 plays a dual role, both neurotoxic and neuroprotective, in the brain 12 
and nervous system, a role modulated by its four receptors (Milatovic et al., 2011). 13 
Different binding affinities, varying cellular expression profiles, and attenuation of 14 
secondary messengers of these receptors lead to intricate, and sometimes opposing, 15 
signal transduction. While in Alzheimer's disease and amyotrophic lateral sclerosis it 16 
plays a neurotoxic role (Bazan et al., 2002), in excitotoxicity and cerebral ischemia 17 
scenarios, PGE2 is neuroprotective (Gregory et al., 2008).  Thus, modulation of PGE2 18 
appears critical for neurological function. When PGE2 levels are reduced by 19 
deficiency of synthetic enzymes PLA2 (Gregory et al., 2008), COX-1 and COX-2 20 
(FitzGerald, 2003) or PGE2  receptor (EP1-4), neurological impairment might occur.  21 
Mohri and colleagues (Mohri et al., 2006) have described prostaglandins as 22 
neuroinflammatory molecules that heighten pathological response to demyelination in 23 
twitchier mice. Similarly, the arachidonic acid pathway was shown to be modulated 24 
during cuprizone neurotoxin induced-demyelination and remyelination processes 25 
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(Palumbo et al., 2011). Altogether, these data support a causative relationship 1 
between abnormal PLAA activity and the severe leukoencephalopathy seen in our 2 
patients. 3 
Of special interest is the prominent feature seen in six patients of exaggerated startle 4 
response, previously linked to dysmyelination/hypomyelination disorders, such as 5 
multiple sclerosis (MS).  In 1978, Mertin and Stackpoole showed that treatment with 6 
essential fatty acids, including arachidonic acid, suppresses experimental autoimmune 7 
encephalomyelitis in rats, and isabolished by inhibition of prostaglandin biosynthesis 8 
(Mertin and Stackpoole, 1978). Additionally, decreased inhibition of startle generator 9 
structure was reported to be associated with MS (Ruprecht et al., 2002),. The calcium-10 
independent PLA2 inhibitor was also linked to reduced pre-pulse inhibition of acoustic 11 
startle reflex in other studies (Lee et al., 2009).  12 
Multiple studies link PGE2 and arachidonic acid pathways to neurodegenerative 13 
disorders, but their exact roles in causing white matter disorders remain unclear. We 14 
hypothesize that the prominent startle reflex dys-inhibition in our patients may be 15 
related to brainstem lesions as part of the diffused axonal and myelin damage.  16 
Additional interesting observation was that p.Leu752Phe substitution in PLAA results 17 
inability of the patient fibroblasts to induce IL-6, IL-8, and MIF in response to the 18 
NF-κB activating molecule LPS. While the pathophysiological relevance of this 19 
observation is yet to be determined, an association between neurodegenerative 20 
disorders and inflammatory cytokine responses has been suggested recently (Schmitz 21 
et al., 2015). These cytokines are known for their pleiotropic function and are 22 
implicated in activation of microglia, proliferation, migration, and homing of different 23 
immune and non-immune cells. In addition, PGE2 has been shown to be important 24 
leading to increased production of IL-6 and IL-8(Cho et al., 2014). Thus, taken 25 
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together, our observation may suggest that the pathogenesis of the 1 
leukoencephalopathy linked to the p.Leu752Phe subbstitution in PLAA implicates 2 
inability to mount appropriate inflammatory responses during pre-/post-neonatal 3 
development. 4 
The phenotype of our patients, homozygous for p.Leu752Phe in PLAA and with 5 
reduced cPLA2 activity and PGE2 levels, adds new insights into this axis and its role 6 
in leukoencephalopathic disorders' pathogenesis.  7 
Knockout mouse data provide a clue into potential disease mechanisms seen in the 8 
patients described in this paper. The disturbance in prostaglandin signaling results in a 9 
variety of pathological conditions. PLAA-deficient mice showed some phenotypes, 10 
specifically perinatal death, immature lungs with reduced PGE2, and reduced body 11 
weight similar to that of Ptgs1 (Cox-1)-Ptgs2 (Cox-2) double knockouts (Yu et al., 12 
2006) and Ptgs3 knockouts (Nakatani et al., 2007). The double mutants, as well as 13 
Ptgs4 knockouts (Nguyen et al., 1997) died perinatally due topatent ductus arteriosus, 14 
Ptgs3 knockouts showed perinatal death, possessed immature lungs, and PGE2 levels 15 
were markedly decreased in the organ. The mutants also exhibited decreased body 16 
weight and skin morphological and physiological defects. Additionally, prostaglandin 17 
signaling is implicated for its roles in a range of physiologicalprocesses such as cell 18 
fate decision (Nissim et al., 2014), cell differentiation (Li et al., 2000), and 19 
ciliogenesis (Jin et al., 2014). The inability of Plaa-null mice to survive, which may 20 
stem from impaired neuronal development in the brain, together with our findings that 21 
PGE2 levels were significantly reduced in the brain and the lung of Plaa-null mouse 22 
embryos, raise the possibility that the pathogenesis of the condition we observed in 23 
PLAA-deficient mice and in patients with a non-functional PLAA could be a 24 
developmental defect caused at least partly by ineffective prostaglandin signaling. 25 
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Clearly, the Plaa-null mouse model provides an important tool to study the role of 1 
PLAA in central nervous system development and maintenance. Creating Plaa 2 
conditional knockout mice or Plaa knock-in mice carrying the p.Leu752Phe sequence 3 
variant would enable us to perform more detailed histopathological studies of the 4 
brain and thus to learn what type of leukoencephalopathy is caused by the PLAA 5 
sequence variant described here or by PLAA deficiency. Such an animal model would 6 
further contribute to the understanding of the significant role of arachidonic acid and 7 
PGE2 pathway in the normal development and maintenance of the brain.  8 
In conclusion, we have presented a cohort of patients with progressive microcephaly 9 
and leukoencephalopathy, providing the first documentation of a PLAA-related 10 
disease. Although the interplay between PLAA, the abnormal production of PGE2, 11 
and the resultant hypo-myelination has not been thoroughly delineated, our data 12 
clearly indicated an association of this axis with brain development. Supportive 13 
evidence from the literature and improved understanding of the new players in this 14 
pathway should lead to new therapeutic avenues for intervention in both rare 15 
autosomal recessive disorders and late onset common diseases that involve reduced 16 
central nervous system white matter. 17 
 18 
 19 
 20 
 21 
 22 
 23 
 24 
 25 
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Table 1. Clinical characteristics of patients: Data were collected regarding medical 1 
history, metabolic measurements, imaging, electrophysiological studies and muscle 2 
biopsy. Complete physical, neurological, and developmental examinations were 3 
performed on seven patients. The disease phenotype in all patients was similarly 4 
severe. NA=Not Available. MRI= Magnetic Resonance Imaging. 5 
 SSEP= Somatosensory Evoked Potentials.  6 
Patient A(VI3) A(VI4) A(VI5) A(V6) A(VI10) B(IV2) A(VI1) 
Sex F F M M M M M 
Age (y) 15 11 16 34 5 3 2 
AO  (m) 4 4 3 4 3 2 3 
FTT +++ + +++ +++ ++ +++ +++ 
Progressive 
microcephaly 
+++ 
 
+ +++(*) *+ + +++ + 
Pyramidal 
Signs Lower 
extremities 
 
+++ 
(plegia) 
Babinski 
sign 
+++ 
Babinski 
sign 
+++ 
Babinski sign, 
Clonus 
+++ 
Babinski 
sign 
+++ 
Babinski sign 
++ +++ 
 
Pyramidal 
Signs Upper 
extremities 
++ ++ ++ ++ ++ ++ +++ 
 
Extra-
pyramidal 
Signs 
++ ++ +++ +++ ++ +++ +++ 
GMFCS 
(Level) 
V V V V V V V 
Cognitive and 
Language 
Development 
Severe Severe Severe Severe Severe Severe Severe 
Page 32 of 62
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 32
Patient A(VI3) A(VI4) A(VI5) A(V6) A(VI10) B(IV2) A(VI1) 
Delay 
Exaggerated 
Startle 
Response 
+ + + NA + + + 
Seizures 
 
-  - + +  - +  - 
MRI/CT of 
brain 
Reduce mass 
of white 
matter. Thin 
Corpus 
Callosum 
Delayed  
Myelination 
(especially 
along 
Cortico-
Spinal tract 
and posterior 
Genu of 
Capsula 
Interna (at 
age 13m) 
Worsening 
of brain 
atrophy at 
the age of 
 3 2/12. 
Sparing of 
basal 
ganglia.  
Enlargement 
of 
ventricular 
system 
Thin Corpus 
Callosum 
Normal 
MRI of 
spinal cord 
(at age 1y) 
White matter atrophy 
with 
periventricular lesions 
resemble PVL 
Thin Corpus 
Callosum  (at age 2y) 
Severe 
general 
and 
especially 
white 
matter 
atrophy 
and thin 
Corpus 
Callosum 
 (at age 
30y 
White matter 
atrophy, 
periventricular 
and 
subcortical 
lesions 
Thin Corpus 
Callosum 
Enlargement 
of ventricular 
system 
(at age 1 y 9m) 
Delayed 
myelination. 
Thin Corpus 
Enlargement 
of 
ventricular 
system 
(at age 2y) 
Delayed 
myelination 
(at age 9m) 
Kyphosis/  
Pectus    +/+++ +/+++ +/+++ +++/+++ +/++ /++ -  +/+ 
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Patient A(VI3) A(VI4) A(VI5) A(V6) A(VI10) B(IV2) A(VI1) 
Carinatum 
 Hyper-
trichosis + + NA + +  -  - 
Small joints 
Hyper-
flexibility + + ++  - ++ + + 
Large joints 
Contractures 
+++ 
Rocker 
bottom feet +++ +++ 
+++  
Rocker 
bottom 
feet 
 +++ ++ + 
 Intensive 
sweating of 
palms and 
feet  + +  - + + + + 
Miscellaneous 
Moderate/ 
severe 
hearing 
impairment 
SSEP: 
central 
bilateral 
disturbance 
in central 
tract 
conduction 
above 
brainstem. 
Muscle 
biopsy 
revealed 
sediment of 
SSEP: 
central 
bilateral 
disturbance 
in central 
conduction 
above 
brainstem 
   
Muscle biopsy: mild 
reduction of 
cytochrome C oxidase 
activity. Normal 
Immunohistochemical 
staining. Normal 
muscle cells structure . 
 
 
Occasional 
horizontal 
nystagmus.   
Retinal 
atrophy with 
abnormal 
VEP'S and 
ERG 
responses 
 
  
Page 34 of 62
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 34
Patient A(VI3) A(VI4) A(VI5) A(V6) A(VI10) B(IV2) A(VI1) 
glycogen 
like material 
(PAS 
positive).  
EM 
examination 
confirmed 
accumulation 
of glycogen. 
Normal 
respiratory 
chain 
 1 
AO, age at onset; FTT, failure to thrive; GMFCS, Gross Motor Functional 2 
Classification System; m, months; HC, head circumference 3 
NA, not available. 4 
For all of patients: normal karyotype, level of cholesterol, muscular and lysosomal 5 
enzymes 6 
(*) until the age of approximately 5 years followed by an unexplained gradual 7 
increase in HC up to 75%.   8 
   9 
  10 
 11 
 12 
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Figure legends 
Figure 1. Pedigree of the investigated families. A. Family I: 6 affected individuals 
(filled shapes). B. Family II: containing another affected individual. A high rate of 
consanguinity and an AR pattern of inheritance are evident. C. Photographs of patient 
VI5 (pedigree A) illustrating: coarse facial features (a) pectus carinatum, dystonic 
posturing, rigidity/freezing and shortening of tendons (b, c), and rocker bottom feet 
(d). 
D. Patients' brain MRI. a and b. T1 Brain MRI of patient IV2 (family II), at 1 year of 
age, shows white matter atrophy. Corpus callosum is complete but thin. c (T2 MRI 
Imaging) and d (T1 MRI Imaging). Brain MRI of patient VI3 (family I), at 14 years, 
shows moderate white matter atrophy and severe corpus callosum thinning. e (T2 
MRI Imaging) and f (T1 MRI Imaging). Brain MRI of patient V4 (family I), at age 32 
years, shows severe general atrophy. The cortex is usually preserved but very thin, 
corpus callosum is complete but also very thin. The basal ganglia appear normal.  
Figure 2. A. Haplotypes for each family member were constructed for 11 
microsatellite markers spanning the neurodegenerative interval. Markers analyzed are 
given on the left, according to their physical order. Haplotypes are represented by 
bars, with the disease-associated haplotype shaded in gray. Reduction in the affected 
linked region to 1.9Mb was due to healthy individuals VI6 and IV4 who bear fraction 
of the affected haplotype in a homozygous manner.  
B. Physical location of genes and predicted transcripts in the chromosome 9 linked 
interval. Asterisk denotes genes not approved by the HUGO Gene Nomenclature 
Committee (HGNC). “Strand” refers to transcription orientation. Bold names indicate 
gene analyzed by direct sequencing. Physical location obtained from UCSC Human 
Genome Browser Gateway (hg19 assembly).C. Analysis of the c.2254C>T mutation 
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in exon 14 of PLAA. Sequence analysis is shown for an unaffected individual, an 
obligatory carrier, and an affected individual. D. Sequence alignment of human PLAA 
to orthologues in the mutation area. The leucine at position 752 (boxed) in this protein 
is highly conserved throughout evolution. E. Effect of L752F (Leu→Phe) substitution 
on PLAA structure. Shown is a ribbon diagram of the PUL domain of PLAA (PDB ID 
3EBB) which adopts a banana like shaped Armadillo domain.  The conserved 
residues of PLAA (homo sapiens, mus musculus, rattus norvegicus, Xenopus laevis, 
and Saccharomyces cerevisiae) are displayed in stick-representation and form the 
putative binding site of PLAA.  Mutation of Leu752 shown in ball-representation 
disrupts the rigid leucine network that tightly holds together the Armadillo domain. 
Figure 3. mRNA levels for PLAA and confocal microscopy of fibroblasts for the 
presence of PLAA protein. A. Presence of full length transcript for PLAA from 
fibroblasts of affected patients and the control subject based on PCR. B. RT-qPCR for 
the detection of PLAA transcript from fibroblasts of a patient versus the healthy 
control normalized to four house-keeping genes coding for human 18S RNA, 
GAPDH, PolB, and L19 ribosomal protein. Arithmetic means ± standard deviations 
from three biological replicates performed in triplicate were shown. C. Fibroblasts 
(nPLAA or mPLAA) were counterstained with DAPI (blue) for the nucleus and with 
fluorophore conjugated phalloidin (red) for actin. Cells were fixed, subjected to 
immunofluorescence staining for PLAA (green), and observed by confocal 
microscopy. D. Mean fluorescence intensity of regions of interest corresponding to 
the cytoplasm and nucleus of imaged cells (Image J processing program, NIH). Figure 
represents results from 3 sets of images and error bars represent standard deviations. 
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Figure 4. PGE2 levels and cPLA2 activity are low in patients' fibroblasts, and 
could be rescued. A. Levels of PGE2 in cell culture media after 24 hours of 
stimulation with LPS or cholera toxin Levels of PGE2 were normalized against 
protein concentrations in the supernatants. All cells were primary human fibroblasts 
except RAW 264.7 cells which are murine macrophage like cells and used as a 
positive control. B. Activity of cPLA2 in the membrane fractions of fibroblasts and 
RAW 264.7 macrophages. Cells were stimulated with or without LPS for 24 hours 
before harvesting and purification of the membrane fractions. The cPLA2 activity was 
normalized to amount of proteins added to the assay. C. PGE2 levels in the cell 
culture media after transfection with CMV promoter-based pIRES2-DsRed2 plasmid 
containing the native PLAA gene and a fluorescent marker of transfection. Cells were 
treated as follow: ctl = no transfection; V = transfection with empty vector; PLAA = 
transfection with plasmid vector containing the wild type PLAA. D. cPLA2 activity 
from membrane fractions of fibroblasts after transfection with a plasmid containing 
the nPLAA in a CMV promoter-based vector system and a fluorescent marker of 
transfection. E-G. Fold changes in transcripts for IL-6, IL-8, and MIF based on RT-
qPCR. Arithmetic means ± standard deviations from three independent experiments 
performed in triplicate were plotted and the data were analyzed using one way 
ANOVA with Tukey post-hoc correction. 
Figure 5. PGE2 levels in embryonic mouse tissues. WT, Plaa+/-, and Plaa-/- embryos 
were sacrificed at E18.5 and organs were isolated and prostaglandin levels determined 
for the lung (A), brain (B), liver (C), and heart (D). Data represented arithmetic means 
± standard deviations from tissues representing 3 WT, 3 Plaa+/-, and 4 Plaa-/- embryos 
and obtained from three independent littermates. Significance was determined by one 
Page 38 of 62
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
 38
way ANOVA with Tukey post-hoc correction. * denotes p<0.05   *** denotes 
p<0.001.  
Figure 6. Histopathology of embryonic mouse tissues. Lungs (A), brain cerebral 
cortex (B), and skin (C) were H&E stained and analyzed in a blinded fashion.  
Tissues representing 2 WT, 2 Plaa+/-, and 4 Plaa-/- embryos were analyzed. Multiple 
fields for each tissue were visualized and typical representations are shown with 
magnifications. 
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Figure 1. Pedigree of the investigated families. A. Family I: 6 affected individuals (filled shapes). B. Family 
II: containing another affected individual. A high rate of consanguinity and an AR pattern of inheritance are 
evident. C. Photographs of patient VI5 (pedigree A) illustrating: coarse facial features (a) pectus carinatum, 
dystonic posturing, rigidity/freezing and shortening of tendons (b, c), and rocker bottom feet (d).  
D. Patients' brain MRI. a and b. T1 Brain MRI of patient IV2 (family II), at 1 year of age, shows white matter 
atrophy. Corpus callosum is complete but thin. c (T2 MRI Imaging) and d (T1 MRI Imaging). Brain MRI of 
patient VI3 (family I), at 14 years, shows moderate white matter atrophy and severe corpus callosum 
thinning. e (T2 MRI Imaging) and f (T1 MRI Imaging). Brain MRI of patient V4 (family I), at age 32 years, 
shows severe general atrophy. The cortex is usually preserved but very thin, corpus callosum is complete 
but also very thin. The basal ganglia appear normal.  
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Figure 2. A. Haplotypes for each family member were constructed for 11 microsatellite markers spanning the 
neurodegenerative interval. Markers analyzed are given on the left, according to their physical order. 
Haplotypes are represented by bars, with the disease-associated haplotype shaded in gray. Reduction in the 
affected linked region to 1.9Mb was due to healthy individuals VI6 and IV4 who bear fraction of the affected 
haplotype in a homozygous manner.  
B. Physical location of genes and predicted transcripts in the chromosome 9 linked interval. Asterisk denotes 
genes not approved by the HUGO Gene Nomenclature Committee (HGNC). “Strand” refers to transcription 
orientation. Bold names indicate gene analyzed by direct sequencing. Physical location obtained from UCSC 
Human Genome Browser Gateway (hg19 assembly).C. Analysis of the c.2254C>T mutation in exon 14 of 
PLAA. Sequence analysis is shown for an unaffected individual, an obligatory carrier, and an affected 
individual. D. Sequence alignment of human PLAA to orthologues in the mutation area. The leucine at 
position 752 (boxed) in this protein is highly conserved throughout evolution. E. Effect of L752F (Leu→Phe) 
substitution on PLAA structure. Shown is a ribbon diagram of the PUL domain of PLAA (PDB ID 3EBB) which 
adopts a banana like shaped Armadillo domain.  The conserved residues of PLAA (homo sapiens, mus 
musculus, rattus norvegicus, Xenopus laevis, and Saccharomyces cerevisiae) are displayed in stick-
representation and form the putative binding site of PLAA.  Mutation of Leu752 shown in ball-representation 
disrupts the rigid leucine network that tightly holds together the Armadillo domain.  
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Figure 3. mRNA levels for PLAA and confocal microscopy of fibroblasts for the presence of PLAA protein. A. 
Presence of full length transcript for PLAA from fibroblasts of affected patients and the control subject based 
on PCR. B. RT-qPCR for the detection of PLAA transcript from fibroblasts of a patient versus the healthy 
control normalized to four house-keeping genes coding for human 18S RNA, GAPDH, PolB, and L19 
ribosomal protein. Arithmetic means ± standard deviations from three biological replicates performed in 
triplicate were shown. C. Fibroblasts (nPLAA or mPLAA) were counterstained with DAPI (blue) for the 
nucleus and with fluorophore conjugated phalloidin (red) for actin. Cells were fixed, subjected to 
immunofluorescence staining for PLAA (green), and observed by confocal microscopy. D. Mean fluorescence 
intensity of regions of interest corresponding to the cytoplasm and nucleus of imaged cells (Image J 
processing program, NIH). Figure represents results from 3 sets of images and error bars represent 
standard deviations.  
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Figure 4. PGE2 levels and cPLA2 activity are low in patients' fibroblasts, and could be rescued. A. Levels of 
PGE2 in cell culture media after 24 hours of stimulation with LPS or cholera toxin Levels of PGE2 were 
normalized against protein concentrations in the supernatants. All cells were primary human fibroblasts 
except RAW 264.7 cells which are murine macrophage like cells and used as a positive control. B. Activity of 
cPLA2 in the membrane fractions of fibroblasts and RAW 264.7 macrophages. Cells were stimulated with or 
without LPS for 24 hours before harvesting and purification of the membrane fractions. The cPLA2 activity 
was normalized to amount of proteins added to the assay. C. PGE2 levels in the cell culture media after 
transfection with CMV promoter-based pIRES2-DsRed2 plasmid containing the native PLAA gene and a 
fluorescent marker of transfection. Cells were treated as follow: ctl = no transfection; V = transfection with 
empty vector; PLAA = transfection with plasmid vector containing the wild type PLAA. D. cPLA2 activity from 
membrane fractions of fibroblasts after transfection with a plasmid containing the nPLAA in a CMV promoter-
based vector system and a fluorescent marker of transfection. E-G. Fold changes in transcripts for IL-6, IL-
8, and MIF based on RT-qPCR. Arithmetic means ± standard deviations from three independent experiments 
performed in triplicate were plotted and the data were analyzed using one way ANOVA with Tukey post-hoc 
correction.  
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Figure 5. PGE2 levels in embryonic mouse tissues. WT, Plaa+/-, and Plaa-/- embryos were sacrificed at 
E18.5 and organs were isolated and prostaglandin levels determined for the lung (A), brain (B), liver (C), 
and heart (D). Data represented arithmetic means ± standard deviations from tissues representing 3 WT, 3 
Plaa+/-, and 4 Plaa-/- embryos and obtained from three independent littermates. Significance was 
determined by one way ANOVA with Tukey post-hoc correction. * denotes p<0.05   *** denotes p<0.001.  
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Figure 6. Histopathology of embryonic mouse tissues. Lungs (A), brain cerebral cortex (B), and skin (C) 
were H&E stained and analyzed in a blinded fashion.  Tissues representing 2 WT, 2 Plaa+/-, and 4 Plaa-/- 
embryos were analyzed. Multiple fields for each tissue were visualized and typical representations are shown 
with magnifications.  
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Supplementary Materials and Methods  
Western blot analysis 
Ubiquitin. Western blotting was performed with a SDS-PAGE Electrophoresis 
System as described previously (Khayat et al., 2008). Briefly, 30 µg protein samples 
from healthy controls' and patients' fibroblasts were prepared in a reducing sample 
buffer, and then electrophoresed on a 7.5% Tris gel with Tris running buffer; blotted 
to nitrocellulose membrane; and probed with mouse anti-ubiquitin (Santa Cruz 
Biotechnology, Inc., Santa Cruz, CA) antibodies. A horseradish peroxidase-
conjugated goat anti-mouse secondary antibody (Santa Cruz) was then added, and 
proteins detected by autoradiography using enhanced chemiluminescence substrate 
(Pierce ECL kit, Thermo Scientific, Grand Island, NY).  
 
Yeast experiments  
Wild type DOA1 gene expressing plasmid and DOA1 deleted yeast strain 
(Saccharomyces cerevisiae) were kindly provided by Prof. Tzachi Pilpel and Dr. Orna 
Dahan (Weizmann Institute of Science, Israel). Mutant p.Leu677Phe (Leucine→
Phenylalanine) DOA1 was produced using the Quikchange site-directed Wild type or 
mutant DOA1 expressing plasmid, or a mock plasmid, was transformed into the 
indicated yeast strain by standard lithium acetate method. The yeast was grown on a 
regular synthetic medium at 30
o
C, 37
o
C or at 30
o
C supplemented with 0.5 µg/ml 
cycloheximide. After three days, the growth of the yeast was assessed.  
 
Cell biology studies 
Immunofluorescence Confocal Microscopy 
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Confocal microscopy was performed on fixed fibroblasts by established procedures 
with slight modifications. Briefly, nPLAA and mPLAA were treated with 10 µg/mL 
LPS for 60 min, with LPS untreated cells serving as controls, before fixation with 4% 
paraformaldehyde. Subsequently, fibroblasts were permeabilized with 0.5% Triton X-
100. Goat anti-p65 C-20 antibody (Santa Cruz) or rabbit anti-PLAA antibody 
(GenWay Biotech, Inc., San Diego, CA), and Alexa Fluor 488 donkey anti-goat 
antibody (Molecular Probes, Carlsbad, CA) or Alexa Fluor 488 donkey anti-rabbit 
antibody, were used as primary and secondary antibodies, respectively, as appropriate. 
Samples stained with secondary antibody alone were used as negative controls. 
Fibroblasts were then counterstained with DAPI (Life Technologies, Grand Island, 
NY) and Alexa Fluor 594 phalloidin (Life Technologies) to stain the nucleus and 
actin, respectively. Fibroblasts were subsequently visualized using a Zeiss LSM510 
confocal scanning microscope. 
Plaa Gene Targeting  
A mouse genomic library, ES129SvJ, was screened for clones containing the Plaa 
gene. Two overlapping pUC18 clones, 10-1-1A carrying a ~17-kb Plaa upstream-
intron 2 region and 7-2-1A carrying a ~12-kb Plaa intron 2-intron 10 region, were 
validated for the organization of the gene by DNA restriction enzyme digestion and 
sequence analysis, and used for knockout vector construction. A 3.1-kb HindIII-BglII 
fragment (intron 1, 5’ homology arm), and a 6.0-kb SalI-Asp718 (located in pUC18) 
fragment containing exons 8-10 (3’ homology arm) were subcloned into a plasmid 
vector, pBluescript II KS (-) (Agilent Technologies). A positive selection marker 
PGKneobpA (Soriano et al., 1991) flanked by loxP sites was inserted between two 
homology arms, and a negative selection marker HSVtkpA (Mansour et al., 1988) was 
inserted between pBluescript and the 5’ homology arm (Figure S2, A).  
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The vector was linearized at the end of the 3’ homology arm by Asp718 and 
electroporated into 129S inbred Tc1 (George et al., 2007)kindly provided by Phillip 
Leder, Harvard Medical School, Boston, MA) and B6129F1 hybrid G4 (George et al., 
2007) kindly provided by Andras Nagy, Samuel Lunenfeld Research Institute, Mount 
Sinai Hospital, NY) mouse embryonic stem (ES) cells.  
A 3’-flanking probe was used in Southern blot for the identification of targeted clones 
(Figure S2, A). Mutant ES cell clones were injected into C57BL/6J blastocysts. We 
crossed chimeric mice and C57BL/6J to produce animals heterozygous for the Plaa 
knockout (KO)
neo
 allele. To establish mutant lines with Plaa exon-2-7 deletion (KO) 
allele, we crossed KO
neo
/+ mice to a germ-line cre deleter strain, Zp3-cre transgenic 
mouse, on a C57BL/6J background (Lewandoski et al., 1997)C57BL/6J-Tg(Zp3-
cre)93Knw/J, The Jackson Laboratory, Stock Number: 003651). The mice were 
maintained by backcrossing to C57BL/6J. 
Genotyping 
We genotyped mice initially by Southern blot analysis using the 3’ probe, and 
subsequently by PCR (Figure S2, B&C). The 3’ probe was generated by PCR with 
primers: XB-X-Plaa, 5’-CTTCTCGAGTTCCTGAATGTCTGGGAAAA-3’; and 
XB-B-Plaa, 5’-ACGAGATCTAGTGATGTGGCAATGCCTTT-3’; and mouse 
genomic DNA as the template. The PCR product was treated with Klenow DNA 
polymerase, digested with BglII, and subcloned into pBluescript II SK (-) at EcoRV 
and BamHI sites (pPlaa 3’ XB). The digestion of the plasmid pPlaa 3’ XB by XhoI 
and XbaI restriction enzymes released a ~450-bp DNA fragment corresponding to 
Plaa exon 13 and its flanking region. Genotyping PCR was performed with the 
following primers: PlaaWTF, 5’-GGGGGTGGCGTTCCATGTGT-3’; PlaaM+F, 5’-
GTGGGGCAGGACAGCAAG-3’; PlaaM-F, 5’-CCATTTGGCTTTTTGGTCTT-3’; 
Page 56 of 62
ScholarOne, 375 Greenbrier Drive, Charlottesville, VA, 22901  Support (434) 964 4100
Brain
For Peer Review
and PlaaCMR, 5’-CCACCTCCCGTCACTAACACTCCA-3’. PCR conditions for the 
genotyping will be provided upon request. 
Supplementary Results 
Functional Effects of p.Leu752Phe on PLAA 
While the ∆DOA1 strain displayed abrogated growth, transformation of the ∆DOA1 
strain with a plasmid expressing either the native DOA1 gene or its p.Leu677Phe 
variant, which corresponds to Leu752 in human PLAA, completely rescued the 
growth phenotype of S. cerevisiae ∆DOA1 mutant strain (data not shown). Likewise, 
we found no evidence of effect of p.Leu752Phe variation of PLAA on ubiquitin 
depletion in fibroblasts from healthy controls versus patients based on Western blot 
analysis (data not shown). 
 NF-кB Recruitment to the Nucleus is Unaffected by p.Leu752Phe in the PLAA.  
As the secretion of PGE2 as well as the activity of cPLA2 was decreased in mPLAA 
fibroblasts, we investigated whether NF-кB signaling was intact. We stimulated 
nPLAA and mPLAA cells with 10 µg/mL LPS for 60 min and compared nuclear 
localization of p65 by confocal microscopy. Unstimulated nPLAA and mPLAA 
fibroblasts exhibited comparable fluorescent staining primarily in the cytoplasm with 
little to no nuclear staining (Figure S1A,B). Upon stimulation with LPS, both nPLAA 
and mPLAA fibroblasts showed localized NF-кB staining primarily in the nucleus, 
with no significant differences between cell types (nPLAA versus mPLAA fibroblasts). 
These data suggested that the NF-кB signaling pathway remained intact and that 
differences in phenotype observed for mPLAA fibroblasts could be localized 
downstream of NF-кB signaling. 
Wnt Signaling is Not Affected by p.Leu752Phe PLAA 
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β-catenin mediated wingless integration (Wnt) signaling has been shown to play an 
important role in early embryonic development, neurogenesis, central nervous system 
morphogenesis, hirsutism, sweat gland morphology, short tendons, and kyphosis 
(Haara et al., 2011 ; Joksimovic and Awatramani, 2014; Toribio et al., 2010; Zhang et 
al., 2014).(Chenn, 2008). Han and collegues have shown this pathway to be regulated 
by cPLA2a (Han et al., 2008). Therefore, we investigated Wnt signaling by examining 
levels of non-phospho (active) β-catenin in nPLAA versus mPLAA fibroblasts with 
and without LPS stimulation. As shown in Figure S1C, the levels of active β-catenin 
were increased after LPS stimulation to a similar extent in both types of fibroblasts. 
These data indicated that the variant PLAA in our patients did not alter canonical Wnt 
signaling pathway. 
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Supplementary Figure Legends 
Figure S1. Evaluation of NF-кB translocation and Wnt signaling. A. Samples (see 
legends for Figure 4) were counterstained with DAPI (blue) for the nucleus and with 
fluorophore conjugated phalloidin (red) for actin. Cells were stimulated with or 
without LPS for 1 h, then fixed and subjected to immunofluorescence staining for p65 
of NF-кB (green). B. Mean fluorescence intensity of regions of interest (Image J 
processing program) corresponding to the nucleus and cytoplasm of cells stimulated 
with and without LPS is shown. Figure represents results from 3 sets of images and 
error bars indicate standard deviations. C. The whole cell lysates from nPLAA and 
mPLAA fibroblasts with and without LPS treatment were subjected to Western blot 
analysis and probed with non-phospho (active) β-catenin antibodies. Antibodies to β-
tubulin were used as a loading control. Three independent experiments were 
performed and fold changes in the level of β-catenin (based on densitometer scanning 
of the bands) and normalized to the internal control with and without LPS treatment 
are shown.  
Figure S2. Plaa gene targeting. We replaced an exon-2-7 region of the mouse Plaa 
gene with a neo cassette flanked by loxP sites.  The cassette was subsequently 
removed via cre-loxP recombination. The Plaa mutant allele ith neo cassette and the 
one without the cassette resulted in the same phenotype. A. Maps of the Plaa wild-
type (WT) allele, knockout (KO) vector, KO
neo
 allele, and KO
 
allele. Exons 1-14 are 
shown as boxes. Blue, pink, yellow, and red triangles indicate genotyping primers: 
PlaaWT, PlaaM+F, PlaaM-F, and PlaaCMR, respectively. A, Asp718; BI, BglI; BII, 
BglII; H, HindIII; and S, SalI. B. Southern blot analysis of genomic DNA isolated 
from three Plaa-KO
neo
/+ mouse embryonic stem cell clones and a random integration 
clone (R). The 3’ flanking probe hybridized to a 22.6-kb BglI DNA fragment from 
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WT allele, and a 14.7-kb BglI DNA fragment from KO
neo
 allele. The neo probe also 
hybridized to the 14.7-kb BglI DNA fragment. We identified three ES cell clones that 
incoorporated the Plaa mutation by Southern blot analysis. The clones #27 and 75 
were derived from Tc1 ES cells; the clone #52 was derived from G4 ES cells. The 
clones #27 and 52 transmitted the mutant allele to the germ line of the mouse.  C. 
PCR genotyping of the mouse. The upper panel shows genotyping results for E14.5 
embryos produced by Plaa-KO
neo
 heterozygous intercrosses; the lower panel shows 
genotyping results for Plaa-KO lines.  
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